Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
Chemotherapy has been the main treatment option for multiple myeloma for several decades. However, a considerable increase in the life expectancy was observed in multiple myeloma patients when thalidomide, bortezomib and lenalidomide had been introduced into clinical practice. Nevertheless, the dise...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Russo |
| منشور في: |
Practical Medicine Publishing House
2016-10-01
|
| سلاسل: | Клиническая онкогематология |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://bloodjournal.ru/index.php/coh/article/view/513 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|